• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用固体分散体和包衣技术制备并评价硝苯地平日一次缓控释系统的制剂及其药代动力学。

Formulation and pharmacokinetic evaluation of once-daily sustained-released system of nifedipine with solid dispersion and coating techniques.

机构信息

Department of Pharmaceutics, School of Pharmacy, Luzhou Medical College, No. 3-319, Zhongshan Road, Luzhou, 646000, Sichuan Province, P. R. China.

出版信息

Arch Pharm Res. 2013 Jul;36(7):864-73. doi: 10.1007/s12272-013-0076-8. Epub 2013 Mar 6.

DOI:10.1007/s12272-013-0076-8
PMID:23463334
Abstract

A novel sustained-release system was developed for poorly water-soluble drugs by applying solid dispersion (SD) technique to improve the solubility. The SD systems composed of polyvinyl pyrrolidone and stearic acid could not control the release of nifedipine. When the above SD granules were coated with ethylcellolulose (EC10, 45 and 100cp), the dissolution rate extended from 16 to 20 h. When the concentration of EC100cp was increased to 4-6 %, the sustained-release formulation F7 and F8 prepared with 4 % EC100cp and 6 % EC100cp, respectively, could control the drug release in a better manner, namely, they could control drug release in the initial hours with a high cumulative amount of drug at 24 h. The mechanism of drug release from F7 and F8 was diffusion coupled with erosion. When immediate-release capsules was orally administered to rabbits, its absorption was very rapid with a short elimination half-life, while a prolonged maintenance of the plasma drug level up to 24 h was obtained for F7 and F8. Furthermore, the oral bioavailability of F7 and F8 was significantly improved. The results suggested that this novel sustained-release system would be a promising system to improve the solubility and sustain the absorption of poorly water-soluble drugs.

摘要

应用固体分散技术开发了一种新的难溶性药物缓释系统,以提高其溶解度。由聚乙烯吡咯烷酮和硬脂酸组成的 SD 系统不能控制硝苯地平的释放。当上述 SD 颗粒用乙基纤维素(EC10、45 和 100cp)包衣时,溶解速率从 16 小时延长至 20 小时。当 EC100cp 的浓度增加到 4-6%时,分别用 4%EC100cp 和 6%EC100cp 制备的缓释制剂 F7 和 F8 可以更好地控制药物释放,即它们可以在最初几小时内控制药物释放,24 小时时药物的累积量很高。F7 和 F8 中药物的释放机制是扩散偶联侵蚀。当速释胶囊口服给予兔子时,其吸收非常迅速,半衰期短,而 F7 和 F8 则可以将血浆药物水平维持在 24 小时以上。此外,F7 和 F8 的口服生物利用度显著提高。结果表明,这种新的缓释系统有望提高难溶性药物的溶解度和维持其吸收。

相似文献

1
Formulation and pharmacokinetic evaluation of once-daily sustained-released system of nifedipine with solid dispersion and coating techniques.采用固体分散体和包衣技术制备并评价硝苯地平日一次缓控释系统的制剂及其药代动力学。
Arch Pharm Res. 2013 Jul;36(7):864-73. doi: 10.1007/s12272-013-0076-8. Epub 2013 Mar 6.
2
Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation.新型缓释系统——尼伐地平固体分散颗粒崩解控制型骨架片(DCMT)的研制(II):体内评价
J Control Release. 2006 May 1;112(1):51-6. doi: 10.1016/j.jconrel.2006.01.020. Epub 2006 Mar 20.
3
Multi-unit controlled release systems of nifedipine and nifedipine:pluronic F-68 solid dispersions: characterization of release mechanisms.
Drug Dev Ind Pharm. 2002 Mar;28(3):275-85. doi: 10.1081/ddc-120002843.
4
Development and evaluation of nifedipine controlled release tablets prepared using mucoadhesive swellable polymer.采用粘膜粘附可溶胀聚合物制备硝苯地平控释片的研制与评价。
Pharm Dev Technol. 2011 Oct;16(5):536-41. doi: 10.3109/10837450.2010.502176. Epub 2010 Oct 18.
5
Development of nifedipine-loaded coated gelatin microcapsule as a long acting oral delivery.载硝苯地平包衣明胶微胶囊作为长效口服制剂的研发。
Arch Pharm Res. 2009 Jan;32(1):127-32. doi: 10.1007/s12272-009-1126-0. Epub 2009 Jan 29.
6
Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug.制备并表征含有难溶性药物固体分散体颗粒的 pH 非依赖性缓释片剂。
Int J Pharm. 2011 Aug 30;415(1-2):83-8. doi: 10.1016/j.ijpharm.2011.05.052. Epub 2011 May 27.
7
Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.新型缓释系统的研发——含尼伐地平固体分散颗粒的崩解控制型骨架片(DCMT)
J Control Release. 2005 Nov 28;108(2-3):386-95. doi: 10.1016/j.jconrel.2005.08.024. Epub 2005 Oct 25.
8
The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in man.硝苯地平从多孔亲水性基质中的释放动力学及其在人体中的药代动力学。
Pharmazie. 1988 Dec;43(12):845-8.
9
Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.采用乳化-溶剂扩散法制备莪术油缓释微球及其自乳化和油的生物利用度研究。
Colloids Surf B Biointerfaces. 2006 Mar 1;48(1):35-41. doi: 10.1016/j.colsurfb.2005.12.011. Epub 2006 Feb 9.
10
Formulation and In Vitro and In Vivo Evaluation of Lipid-Based Terbutaline Sulphate Bi-layer Tablets for Once-Daily Administration.双层硫酸特布他林脂质体片的制剂研究及其每日一次给药的体外与体内评价。
AAPS PharmSciTech. 2016 Jun;17(3):727-34. doi: 10.1208/s12249-015-0404-z. Epub 2015 Sep 3.

引用本文的文献

1
Novel Curcumin Derivative-Decorated Ultralong-Circulating Paclitaxel Nanoparticles: A Novel Delivery System with Superior Anticancer Efficacy and Safety.新型姜黄素衍生物修饰的超长效循环紫杉醇纳米粒子:一种具有优异抗癌疗效和安全性的新型给药系统。
Int J Nanomedicine. 2022 Nov 14;17:5265-5286. doi: 10.2147/IJN.S369761. eCollection 2022.
2
The Effects of a Novel Curcumin Derivative Loaded Long-Circulating Solid Lipid Nanoparticle on the MHCC-97H Liver Cancer Cells and Pharmacokinetic Behavior.新型姜黄素衍生物长循环固体脂质纳米粒对 MHCC-97H 肝癌细胞的作用及药代动力学行为。
Int J Nanomedicine. 2022 May 17;17:2225-2241. doi: 10.2147/IJN.S363237. eCollection 2022.